Benjamin Levy, MD, a gastroenterologist at the University of Chicago Medicine, recently spoke with Becker’s to discuss the factors having a positive and negative impact on gastroenterologists.
Trending
- USDH’s AI-Driven Colonoscopy Innovation and Market Expansion: A Disruptive Force in U.S. Preventive Medicine (AInvest)
- Roche’s Metabolic Drug Strategy Extends to the Liver Disease MASH With $2.4B 89bio Acquisition (MedCity News)
- How to protect physician autonomy as GI consolidates (Becker’s GI & Endoscopy)
- GutGPT: A multidimensional knowledge-enhanced large language model for gastrointestinal medicine (ScienceDirect)
- 288 new CPT codes cover digital health, AI and more (AMA)
- The Prognostic Power of ctDNA Testing in Patients With Colorectal Cancer (Medscape)
- AI Is Becoming Private Equity’s New Playbook (Forbes)
- Rising colorectal cancer rates and ASCs: 5 things to know (Bevker’s GI & Endoscopy)
